(Q38126949)

29 August 2017

title

Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology (English)

1 reference

29 August 2017

0 references

0 references

1 reference

M Obulesu

1

1 reference

29 August 2017

M Jhansilakshmi

series ordinal

2

1 reference

29 August 2017

publication date

12 September 2013

1 reference

International Journal of Neuroscience

29 August 2017

published in

1 reference

29 August 2017

volume

124

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

227-235

1 reference

Mechanisms underlying inflammation in neurodegeneration

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

DNA damage and impairment of DNA repair in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Lipid peroxidation in Alzheimer's disease: emphasis on metal-mediated neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Genetics of Alzheimer's disease: an insight into presenilins and apolipoprotein E instigated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Carotenoids and Alzheimer's disease: an insight into therapeutic role of retinoids in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

High-molecular weight Aβ oligomers and protofibrils are the predominant Aβ species in the native soluble protein fraction of the AD brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Towards retinoid therapy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

CCAAT/enhancer binding protein β expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Particulate matter, oxidative stress and neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Air pollution: mechanisms of neuroinflammation and CNS disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Astrocyte-neuron metabolic relationships: for better and for worse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Inflammatory response in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Neuroinflamm-aging and neurodegenerative diseases: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Astroglial P2X7 receptor current density increased following long-term exposure to rotenone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Relationship between tau pathology and neuroinflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Impact of the CD40-CD40L dyad in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

NSAIDs for the Chemoprevention of Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

WNT5A signaling contributes to Aβ-induced neuroinflammation and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-κB activation in a rat model of Alzheimer's disease induced by amyloid-β(1-42).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Inflammation and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Sinomenine inhibits microglial activation by Aβ and confers neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Interactions between APP secretases and inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

A review: inflammatory process in Alzheimer's disease, role of cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Involvement of ROS in BBB dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Neuroinflammation in Alzheimer's disease and prion disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Inflammatory processes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Nanoparticles induce changes of the electrical activity of neuronal networks on microelectrode array neurochips

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Opioid system and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Role of platelets in neuroinflammation: a wide-angle perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Platelet activation in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Determinants of platelet activation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

PPARgamma, neuroinflammation, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

PPARs in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Peripheral inflammatory biomarkers of Alzheimer's disease: the role of platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

PPAR: a therapeutic target in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Pro-regenerative properties of cytokine-activated astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Astrocytes are active players in cerebral innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Astrocytes: biology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Cytokines: powerful regulators of glial cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Adult mouse astrocytes degrade amyloid-beta in vitro and in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Astroglial connexin immunoreactivity is specifically altered at β-amyloid plaques in β-amyloid precursor protein/presenilin1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Astrocyte modulation of in vitro beta-amyloid neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Soluble CD40 ligand and endothelial dysfunction in aspirin-treated polycythaemia vera patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

The CD40/CD154 receptor/ligand dyad

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Hypoxia influences CD40-CD40L mediated inflammation in endothelial and monocytic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Transcriptional and post-transcriptional regulation of β-secretase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

CD36 overexpression in human brain correlates with beta-amyloid deposition but not with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Cytokine expression and microglial activation in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Microglia as a potential bridge between the amyloid beta-peptide and tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Rho kinase inhibitor fasudil protects against β-amyloid-induced hippocampal neurodegeneration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Chronic neuron- and age-selective down-regulation of TNF receptor expression in triple-transgenic Alzheimer disease mice leads to significant modulation of amyloid- and Tau-related pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Behavioral effects of CD40-CD40L pathway disruption in aged PSAPP mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Enhanced soluble CD40 ligand and Alzheimer's disease: evidence of a possible pathogenetic role.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Dietary antioxidants and long-term risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Immune cells may fend off Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

Genomic regulation after CD40 stimulation in microglia: Relevance to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2013.831852

10.3109/00207454.2013.831852

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference